Anti-Cancer Agent Avastin Obtained Approval for Additional Indication of Advanced or Recurrent Cervical Cancer
Chugai Pharmaceutical Co Ltd announced that it gained approval by the Japanese Ministry of Health, Labour and Welfare (MHLW) on May 23, 2016, for...
Allergan Launches IBS-D on Tract, New Online Resource to Support Patients with Irritable Bowel Syndrome
Allergan plc launched IBSDonTract.com, an online resource for those living with irritable bowel syndrome with diarrhea (IBS-D). IBS-D, which affects approximately 15 million adults...
Pfizer Announces EMA acceptance for Trumenba (Meningococcal Group B Vaccine) marketing authorization application review
Pfizer Inc announced the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for TRUMENBA® (Meningococcal Group B Vaccine) for review. TRUMENBA...
Novartis announces FortiHFy clinical programme of Entresto
• Fortifying Heart Failure clinical evidence and patient quality of life (FortiHFy) is an umbrella clinical program comprising over 40 active or planned trials...
Merck and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting
• 14 avelumab abstracts at ASCO 2016 highlight significant progress being made by the collaboration between Merck KGaA, Darmstadt,...
Novartis to present pivotal data in hematologic and solid tumor cancers at 2016 ASCO Annual Meeting
• First data from two treatment-free remission (TFR) studies of Ph+ CML patients treated with Tasigna®both in front-line and second-line following Glivec®*• First genomic...
Merck & Co Inc Final overall survival (OS) dataData from KEYNOTE-006 and KEYNOTE-001 in Advanced Melanoma To Be Presented at 2016 ASCO Annual Meeting
Final Overall Survival Data from KEYNOTE-006 To Be Presented at ASCO; KEYTRUDA, the First Anti-PD-1 Monotherapy to Demonstrate Overall Survival Compared to Ipilimumab, Shows...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...